Bone regeneration device for bones, and method of use

Information

  • Patent Grant
  • 8109932
  • Patent Number
    8,109,932
  • Date Filed
    Thursday, December 21, 2006
    18 years ago
  • Date Issued
    Tuesday, February 7, 2012
    13 years ago
Abstract
A method of stimulating bone regeneration in a discontinuous section of a long bone in a subject requiring same, comprising the step of applying to said discontinuous section of the bone an effective vacuum for an effective length of time. A device for carrying out the method consisting of a sealable tubular-shaped sleeve or cuff that fits snugly and sealably around the bone section to be treated and that can be evacuated via a port that is integral to the sleeve or port.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The invention is concerned with local bone regeneration for long bones. More specifically, the invention relates to the use of locally-applied vacuum to stimulate osteoblastic activity in long bones with discontinuity defects.


2. Description of the Related Art


Osteogenesis, the growth of new bone, is a part of the normal healing process, and involves recruiting and activating osteoblast cells in the bone. This can be a slow process, particularly in the elderly and after severe trauma to the bone and after disease. The ability to accelerate osteogenesis would speed the healing process after trauma and after orthopedic and dental procedures. Methods to accelerate the process, particularly in local areas of bone, have been a holy grail for scientists for many years.


Current techniques of bone regeneration include: traditional methods such as distraction osteogenesis in which bone is pulled in an appropriate direction to stimulate growth, and bone grafting; and, experimental techniques that include use of drugs such as OP-1 that stimulate osteoblasts, implanting biomaterials laced with molecular signals designed to trigger the body's own repair mechanism, injecting bone marrow stem cells into the affected areas, and, transfusing cells that carry genes that code for bone-repair proteins. None of these methods are totally satisfactory, for a host of reasons. For a review of this subject see: Service, Science, 289:1498 (2000).


Distraction osteogenesis requires a bulky device and requires a very long period before positive results are seen. Bone grafting is limited by the quantity and quality of the patient's bone available for grafting. Biocompatible polymeric matrices without or with natural or recombinant bone morphogenic proteins suffer from a need for a very large and very expensive quantities of these signal proteins. The gene therapy procedure suffers from the general problems of gene therapy in general. The use of the stem cell approach is greatly limited by the scarcity and expense of such cells; for example, in 50-year olds, there is only one stem cell in 400,000 bone marrow cells. (see Service, 2000, above.)


Applicant has previously described a device that applies subatmospheric pressures to a fractured or lesioned area of a flat bone (e.g., scapula), and thereby promotes osteogenesis and consequent bone healing in such areas (Lytinas, U.S. Pat. No. 6,491,693, which is incorporated herein by reference). However, for anatomical reasons such a device is not suitable for non-flat long bones of the upper and lower extremities, particularly where blunt trauma from accidents and/or projectiles produces in the long bone discontinuous defects leaving gaps of 2.5 cm and more. In the past such discontinuous defects have been treated orthopedically by grafting into the discontinuity pieces of the bone taken from elsewhere in the body. More often than not, such grafting does not completely fill the discontinuity, thereby leading to poor healing (fibrous) and shortened extremities.


Clearly, there is an acute need for a safe, simple, rapid, inexpensive and efficient device and method for producing osteogenesis in discontinuous regions of long bones. Such a device and method, based in principal on the vacuum technique discovered by the applicant (U.S. Pat. No. 6,491,693) has now been discovered, and is described below.


SUMMARY OF THE INVENTION

A device and method for producing bone regeneration (osteogenesis) in a discontinuous local section of a long bone in a subject requiring same, comprising the step of applying to the local section of the bone a vacuum (subatmospheric pressure) for an effective period of time.


In one embodiment, the discontinuous section of the long bone is sealed from the atmosphere with a flexible, sterilizable sleeve or cuff device of a dimension and curvature suitable to enclose and fit sealably tightly over the discontinuous or fractured section of the long bone, the device being connected through a sealable exit port to a source of vacuum, such that the discontinuous section of the long bone can be evacuated for an appropriate length of time.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a sketch of the sleeve/cuff device of the invention.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

The essence of the invention is the production of bone regeneration (osteoblastic cell-induced osteogenesis) in a desired section of a long bone by the application to this section a vacuum (within the context of this specification the term vacuum is to be considered synonymous with subatmospheric pressure) for an effective length of time.


The method can be applied to any long bone in humans or animals. It can be applied to a wide variety of medical conditions, e.g., a bone that has been shattered by such trauma that produces a discontinuous section that requires osteogenesis; a bone that requires lengthening; a bone that needs reshaping, as after an accident; a bone after surgical removal of a cancerous or cystic section of the bone; and, in bone resorption areas (alveolar region).


The device of the invention is suitable for a variety of long bones, including a femur, a clavicle, ribs, humerus, ulna and radius, carpal and metacarpal bones and their phalanges, tibia, fibula, and, tarsal and metatarsal bones and their phalanges, among others.


At the heart of the invention is a device that produces the vacuum on the discontinuous or fractured section of the long bone. A highly preferred device is an evacuatable sleeve or cuff (the two terms are used interchangeably) that can be fitted around the discontinuous section or fracture of the bone and that can be maintained under vacuum through a port. The evacuation port is continuous with both the interior of the sleeve or cuff and the skin surrounding the bone being treated so that repeated re-evacuations may be easily applied by medical personnel.


In FIG. 1, 1 is a representative example of a long bone being treated; 2 is a representative discontinuity defect; 3 is the sleeve or cuff that encloses the bone both above and below the discontinuity; 4 is the vacuum port that extends from the interior of the sleeve or cuff to the outside the skin; 5 is the sealable port orifice that is connected to a vacuum pump or the like; 6 depicts sealant that is placed between the sleeve or cuff and the bone, above and below the discontinuity; and 7 is the skin.


The sleeve or cuff should be composed of flexible, sterilizable (e.g., autoclavable) material. It may be made of a light biocompatible metal or plastic, and its walls should be sufficiently thick so as not to collapse under vacuum. Snugness of the sleeve or cuff device is accomplished, in part, by fabricating the device so that the curvature of the portion resting against the bone is designed to fit the particular bone being treated, and, in part, by the flexibility of the sleeve or cuff. Sleeves or cuffs with a wide variety of sizes and shapes may be fabricated by well-known methods and kept on hand under sterile conditions.


The sleeve or cuff of the inventive device is hermetically glued to the bone above and below the discontinuity section with any appropriate surgical glue, e.g., an elastic silicone Nexaband Liquid, VPL, Inc. without or with glues of the type of KRAZY GLUE. It is important that the sleeve or cuff have elastic properties so that the vacuum seal will not be broken if the bone moves in place.


The sleeve or cuff, once attached to the bone, is evacuated by a vacuum pump (e.g. Nalgene vacuum pump, although any other vacuum pump is suitable) by means of the port (4 and 5 in FIG. 1). Following attainment of the desired degree of vacuum, the connection between the device and the pump is sealed. As the port extends through the skin, it is readily accessible for repeated evacuations of the system. The degree of vacuum is determined by the extent of the discontinuity. For example, as little as 30 in. Hg is sufficient to induce bone regeneration in a skeletal bone. The vacuum port may also be fitted with an attached vacuum measuring gauge.


The device is maintained in place for an appropriate length of time before being removed. Determination of this appropriate length of time is based on the clinical condition being treated and the degree of regeneration required. This determination does not require undue experimentation by the medical or dental surgeon applying the technique.


The progress of bone regeneration may be followed radiographically, as a plastic version of the inventive device is radiolucent and the new bone is not. The osteoid precursor stage of bone regeneration may not, however, always be visible by X-ray. At an appropriate time, the inventive device may be removed surgically, preferably by cutting it away from the bone by, for example, a dental burr.


The following example merely provides an embodiment of the inventive method, and should not be construed as limiting the claims in any way.


Example 1
The Surgical Protocol

Under sterile conditions, the bone to be treated is reached surgically. Skin, fat, muscles, etc. are blunt-resected from the bone.


The autoclaved sleeve or cuff device is slipped around the desired discontinuity section of the bone, and sealed to the bone with surgical glue (e.g. Nexaband liquid, Veterinary Products Laboratories, Inc.).


The vacuum port of the device is attached to a vacuum pump, and the device evacuated to the desired pressure, e.g. about 30 in. Hg. At this point the vacuum port is sealed so as to maintain the vacuum. The subcutaneous tissues are closed with sutures, e.g., a 4-0 Dexonsuture, and the skin sutured closed.


The degree of vacuum can be monitored by a vacuum gauge attached to the vacuum port.


At an appropriate length of time, e.g., about four weeks, the device (still well-sealed) is removed from the long bone. A bone augmentation at the site of the treatment will be noted.

Claims
  • 1. A method of stimulating new bone formation in a bone with a discontinuity defect, the method comprising: sealing a sleeve or cuff having a port to a first portion of the bone located above the discontinuity defects and a second portion of the bone located below the discontinuity defects, the port being in fluid communication with the discontinuity defect;fluidly connecting a vacuum pump to the port;applying vacuum pressure, produced by the vacuum pump, to the discontinuity defect through the port; andresponsive to the vacuum pressure reaching a predetermined level, sealing the port to maintain the vacuum pressure at the discontinuity defect for an effective period of time.
  • 2. The method according to claim 1, wherein the bone is selected from a group comprising of a femur, a clavicle, ribs, humerus, ulna and radius, carpal and metacarpal bones and their phalanges, tibia, fibula, and tarsal and metatarsal bones and their phalanges.
  • 3. The method according to claim 1, wherein an effective amount of vacuum pressure is greater than or equal to about 30 in Hg.
  • 4. The method according to claim 1, wherein the effective period of time is about four weeks.
  • 5. The method according to claim 1 further comprising determining the effective period of time based on a medical condition being treated and a degree of bone regeneration required.
  • 6. The method according to claim 1 further comprising determining the effective period of time by radiographically viewing bone regeneration in the bone.
  • 7. The method according to claim 1, wherein applying the vacuum pressure to the discontinuity defect further comprises applying the vacuum pressure to the bone through the sleeve or cuff.
  • 8. The method according to claim 1 further comprising: surgically exposing the bone prior to positioning the sleeve or cuff, thereby creating a surgical wound; andclosing the surgical wound after positioning the sleeve or cuff.
  • 9. The method according to claim 1 further comprising: measuring the vacuum pressure applied to the bone;reapplying vacuum pressure as necessary during the effective period of time to maintain an effective amount of vacuum pressure;determining the effective period of time by radiographically viewing bone regeneration in the bone;ceasing the application of vacuum pressure following bone regeneration; andremoving the sleeve or cuff following the effective period of time.
CROSS-REFERENCE TO RELATED APPLICATION

This is a continuing application of copending U.S. application Ser. No. 10/410,610, filed Apr. 10, 2003, the prior application is herewith incorporated by reference in its entirety.

US Referenced Citations (130)
Number Name Date Kind
1355846 Rannells Oct 1920 A
2547758 Keeling Apr 1951 A
2632443 Lesher Mar 1953 A
2682873 Evans et al. Jul 1954 A
2910763 Lauterbach Nov 1959 A
2969057 Simmons Jan 1961 A
3066672 Crosby, Jr. et al. Dec 1962 A
3367332 Groves Feb 1968 A
3520300 Flower, Jr. Jul 1970 A
3568675 Harvey Mar 1971 A
3648692 Wheeler Mar 1972 A
3682180 McFarlane Aug 1972 A
3826254 Mellor Jul 1974 A
4080970 Miller Mar 1978 A
4096853 Weigand Jun 1978 A
4139004 Gonzalez, Jr. Feb 1979 A
4165748 Johnson Aug 1979 A
4184510 Murry et al. Jan 1980 A
4233969 Lock et al. Nov 1980 A
4245630 Lloyd et al. Jan 1981 A
4256109 Nichols Mar 1981 A
4261363 Russo Apr 1981 A
4275721 Olson Jun 1981 A
4284079 Adair Aug 1981 A
4297995 Golub Nov 1981 A
4333468 Geist Jun 1982 A
4373519 Errede et al. Feb 1983 A
4382441 Svedman May 1983 A
4392853 Muto Jul 1983 A
4392858 George et al. Jul 1983 A
4419097 Rowland Dec 1983 A
4465485 Kashmer et al. Aug 1984 A
4475909 Eisenberg Oct 1984 A
4480638 Schmid Nov 1984 A
4525166 Leclerc Jun 1985 A
4525374 Vaillancourt Jun 1985 A
4540412 Van Overloop Sep 1985 A
4543100 Brodsky Sep 1985 A
4548202 Duncan Oct 1985 A
4551139 Plaas et al. Nov 1985 A
4569348 Hasslinger Feb 1986 A
4605399 Weston et al. Aug 1986 A
4608041 Nielsen Aug 1986 A
4640688 Hauser Feb 1987 A
4655754 Richmond et al. Apr 1987 A
4664662 Webster May 1987 A
4710165 McNeil et al. Dec 1987 A
4733659 Edenbaum et al. Mar 1988 A
4743232 Kruger May 1988 A
4758220 Sundblom et al. Jul 1988 A
4787888 Fox Nov 1988 A
4822278 Oliva et al. Apr 1989 A
4826494 Richmond et al. May 1989 A
4838883 Matsuura Jun 1989 A
4840187 Brazier Jun 1989 A
4863449 Therriault et al. Sep 1989 A
4872450 Austad Oct 1989 A
4878901 Sachse Nov 1989 A
4897081 Poirier et al. Jan 1990 A
4906233 Moriuchi et al. Mar 1990 A
4906240 Reed et al. Mar 1990 A
4919654 Kalt et al. Apr 1990 A
4941882 Ward et al. Jul 1990 A
4953565 Tachibana et al. Sep 1990 A
4969880 Zamierowski Nov 1990 A
4985019 Michelson Jan 1991 A
5019086 Neward May 1991 A
5037397 Kalt et al. Aug 1991 A
5086170 Luheshi et al. Feb 1992 A
5092858 Benson et al. Mar 1992 A
5100396 Zamierowski Mar 1992 A
5134994 Say Aug 1992 A
5149331 Ferdman et al. Sep 1992 A
5167613 Karami et al. Dec 1992 A
5176663 Svedman et al. Jan 1993 A
5215522 Page et al. Jun 1993 A
5224947 Cooper et al. Jul 1993 A
5232453 Plass et al. Aug 1993 A
5261893 Zamierowski Nov 1993 A
5278100 Doan et al. Jan 1994 A
5279550 Habib et al. Jan 1994 A
5298015 Komatsuzaki et al. Mar 1994 A
5342376 Ruff Aug 1994 A
5344415 DeBusk et al. Sep 1994 A
5358494 Svedman Oct 1994 A
5437622 Carion Aug 1995 A
5437651 Todd et al. Aug 1995 A
5527293 Zamierowski Jun 1996 A
5549584 Gross Aug 1996 A
5556375 Ewall Sep 1996 A
5607388 Ewall Mar 1997 A
5636643 Argenta et al. Jun 1997 A
5645081 Argenta et al. Jul 1997 A
5807230 Argenta et al. Sep 1998 A
5810840 Lindsay Sep 1998 A
5935136 Hulse et al. Aug 1999 A
5964733 Laabs et al. Oct 1999 A
6071267 Zamierowski Jun 2000 A
6086587 Hawk Jul 2000 A
6135116 Vogel et al. Oct 2000 A
6241747 Ruff Jun 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6345623 Heaton et al. Feb 2002 B1
6359189 Fleischmann Mar 2002 B1
6398767 Fleischmann Jun 2002 B1
6488643 Tumey et al. Dec 2002 B1
6491693 Lytinas Dec 2002 B1
6493568 Bell et al. Dec 2002 B1
6553998 Heaton et al. Apr 2003 B2
6555729 Fleischmann Apr 2003 B1
6557487 Fleischmann May 2003 B1
6673028 Argenta et al. Jan 2004 B1
6712851 Lemperle et al. Mar 2004 B1
6770794 Fleischmann Aug 2004 B2
6814079 Heaton et al. Nov 2004 B2
6863022 Fleischmann Mar 2005 B2
7169151 Lytinas Jan 2007 B1
20010029956 Argenta et al. Oct 2001 A1
20020077661 Saadat Jun 2002 A1
20020115951 Norstrem et al. Aug 2002 A1
20020115952 Johnson et al. Aug 2002 A1
20020120185 Johnson Aug 2002 A1
20020143286 Tumey Oct 2002 A1
20030225347 Argenta et al. Dec 2003 A1
20040039391 Argenta et al. Feb 2004 A1
20040122434 Argenta et al. Jun 2004 A1
20050028828 Heaton et al. Feb 2005 A1
20050043659 Challis et al. Feb 2005 A1
20050283105 Heaton et al. Dec 2005 A1
20080275409 Kane et al. Nov 2008 A1
Foreign Referenced Citations (29)
Number Date Country
550575 Aug 1982 AU
745271 Apr 1999 AU
755496 Feb 2002 AU
2005436 Jun 1990 CA
26 40 413 Mar 1978 DE
43 06 478 Sep 1994 DE
295 04 378 Oct 1995 DE
0100148 Feb 1984 EP
0117632 Sep 1984 EP
0161865 Nov 1985 EP
0358302 Mar 1990 EP
1018967 Aug 2004 EP
692578 Jun 1953 GB
2 195 255 Apr 1988 GB
2 197 789 Jun 1988 GB
2 220 357 Jan 1990 GB
2 235 877 Mar 1991 GB
2 333 965 Aug 1999 GB
2 329 127 Aug 2000 GB
4129536 Apr 1992 JP
71559 Apr 2002 SG
WO 8002182 Oct 1980 WO
WO 8704626 Aug 1987 WO
WO 9010424 Sep 1990 WO
WO 9309727 May 1993 WO
WO 9420041 Sep 1994 WO
WO 9605873 Feb 1996 WO
WO 9718007 May 1997 WO
WO 9913793 Mar 1999 WO
Related Publications (1)
Number Date Country
20070123895 A1 May 2007 US
Continuations (1)
Number Date Country
Parent 10410610 Apr 2003 US
Child 11643390 US